249 results
Page 2 of 13
8-K
EX-10.1
ocpebaerhek67wvv2hl
7 Nov 22
Ocuphire to Receive $35 Million Upfront, Nyxol Development Funding and Additional Potential Milestone Payments plus Tiered Double-Digit Royalties
4:16pm
8-K
EX-10.1
1buhs
23 Jun 21
Entry into a Material Definitive Agreement
4:15pm
424B5
sy9qg
7 Jun 21
Prospectus supplement for primary offering
4:21pm
8-K/A
EX-1.1
sxslpx ap7ifekh2
7 Jun 21
Ocuphire Announces $15 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:05pm
8-K/A
EX-10.1
cu9ojl rjtwp0v
7 Jun 21
Ocuphire Announces $15 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:05pm
8-K
EX-10.1
noiq8d
4 Jun 21
Ocuphire Announces $15 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:48pm
8-K
EX-1.1
yh3a5vb10
4 Jun 21
Ocuphire Announces $15 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:48pm
424B5
utn61k7jlvdh2u i2xr
11 Mar 21
Prospectus supplement for primary offering
9:19am
424B4
nrjl108o3knbki1z go
17 Feb 21
Prospectus supplement with pricing info
7:14am